In a murine MRSA pneumonia model, PTX-trained mice showed reduced bacterial burden, preserved lung barrier integrity, and enhanced immune activation, all of which were reversed by GPR183 inhibition or STING deficiency. This evidence concerns the gene STING1 and Methicillin-Resistant Staphylococcus Aureus Pneumonia.